Patents by Inventor Andras Nagy

Andras Nagy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414677
    Abstract: A cell genetically modified to comprise at least one mechanism for providing a local immunosuppression at a transplant site when transplanted in an allogeneic host is, and methods for making and using the same is provided. The cell comprises a set of transgenes, each transgene encoding a gene product that is cytoplasmic, membrane bound, or local acting, and whose function is one or more of: to mitigate antigen presenting cell activation and function; to mitigate graft attacking leukocyte activity or cytolytic function; to mitigate macrophage cytolytic function and phagocytosis of allograft cells; to induce apoptosis in graft attacking leukocytes; to mitigate local inflammatory proteins; and to protect against leukocyte-mediated apoptosis.
    Type: Application
    Filed: February 27, 2023
    Publication date: December 28, 2023
    Applicant: Sinai Health System
    Inventors: Andras Nagy, Jeffrey Harding, Kristina Nagy
  • Patent number: 11820789
    Abstract: The present invention relates to several novel 1-O-glycosylated sphingoid bases and to a production method thereof, as well as to uses of the 1-O-glycosylated sphingoid bases. Sphingoid bases carrying a vinylogous amide-type protecting group are used herein for the production of 1-O-glycosylated sphingoid bases. These vinylogous amide compounds enable an easy and effective production of 1-O-glycosylated sphingoid bases.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: November 21, 2023
    Assignee: CarboCode S.A.
    Inventors: Ferenc Horvath, Györgyi Osztrovszky, Gyula Dekany, Andras Nagy, Piroska Kovacs-Penzes, Jorge Santos
  • Patent number: 11746307
    Abstract: The present invention is directed to biodegradable cleaning compositions, in particular hard surface cleaning compositions, and their use. The compositions according to the invention comprise one or more biosurfactants(s), one or more sorbitan ester(s) and one or more further surfactant(s), which is/are neither a biosurfactant nor a sorbitan ester.
    Type: Grant
    Filed: December 24, 2022
    Date of Patent: September 5, 2023
    Assignee: Evonik Operations GmbH
    Inventors: Zheng Xue, Andras Nagy, Dennis Parrish, Sam Christy, Jennifer Goodyear, Jeff Davidson
  • Publication number: 20230193157
    Abstract: The present invention is directed to biodegradable cleaning compositions, in particular hard surface cleaning compositions, and their use. The compositions according to the invention comprise one or more biosurfactants(s), one or more sorbitan ester(s) and one or more further surfactant(s), which is/are neither a biosurfactant nor a sorbitan ester.
    Type: Application
    Filed: December 24, 2022
    Publication date: June 22, 2023
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Zheng Xue, Andras Nagy, Dennis Parrish, Sam Chiristy, Jennifer Goodyear, Jeff Davidson
  • Patent number: 11591547
    Abstract: The present invention is directed to biodegradable cleaning compositions, in particular hard surface cleaning compositions, and their use. The compositions according to the invention comprise one or more biosurfactants(s), one or more sorbitan ester(s) and one or more further surfactant(s), which is/are neither a biosurfactant nor a sorbitan ester.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: February 28, 2023
    Assignee: Evonik Operations GmbH
    Inventors: Zheng Xue, Andras Nagy, Dennis Parrish, Sam Christy, Jennifer Goodyear, Jeff Davidson
  • Publication number: 20220325289
    Abstract: The present disclosure provides molecular tools, methods and kits for using cell division loci (CDLs) to control cell proliferation in animal cells. CDLs, as provided herein, are loci whose transcription product(s) are expressed during cell division. CDLs may be genetically modified, as described herein, to comprise a negative selectable marker and/or an inducible activator-based gene expression system, which allows a user to permit, ablate, and/or inhibit proliferation of the genetically modified cell(s) by adding or removing an appropriate inducer.
    Type: Application
    Filed: May 26, 2022
    Publication date: October 13, 2022
    Inventors: Andras NAGY, Claudio MONETTI, Qin LIANG
  • Patent number: 11351272
    Abstract: Provided herein are methods for facilitating or inducing stable transgene integration and expression in a proliferating cell, comprising administering to the cell (i) a recombinant AAV (rAAV) vector comprising the transgene flanked by transposon-derived inverted terminal repeat sequences, which sequences are in turn flanked by AAV-derived inverted terminal repeat regions, and (ii) a source of a transposase that recognises said transposon-derived inverted terminal repeat sequences and directs the genomic integration of the transgene into the genome of the proliferating cell. Also provide are methods and transgene delivery systems for the treatment or prevention of diseases affecting, associated with or characterised by proliferating cells.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: June 7, 2022
    Assignees: THE SYDNEYCHILDREN'S HOSPITALS NETWORK (RANDWICK AND WESTMEAD) (INCORPORATING THE ROYAL ALEXANDRA HOSPITAL FOR CHILDREN), CHILDREN'S MEDICAL RESEARCH INSTITUTE, MOUNT SINAI HOSPITAL
    Inventors: Ian Alexander, Sharon Cunningham, Andras Nagy
  • Publication number: 20220016181
    Abstract: Featured are cells and methods of use thereof for modulating an antigen-specific immune response in a subject. The cells comprise a set of transgenes comprising two or more of PD-L1, HLA-G or H2-M3, Cd47, Cd200, FASG or FasL, Ccl21 or Ccl21b, MfgeS and Serpin B9 or Spi6, that shield the cells from immune surveillance (ie. “cloaking genes”). The cells can be used to induce immune tolerance to an antigen (e.g., a donor alloantigen or a self-antigen), or to induce an immune response to (e.g., induce the production of antibodies directed against) a non-self antigen.
    Type: Application
    Filed: December 13, 2019
    Publication date: January 20, 2022
    Inventors: Andras NAGY, Jeffrey HARDING, Kristina NAGY
  • Publication number: 20210332077
    Abstract: The present invention relates to several novel 1-O-glycosylated sphingoid bases and to a production method thereof, as well as to uses of the 1-O-glycosylated sphingoid bases. Sphingoid bases carrying a vinylogous amide-type protecting group are used herein for the production of 1-O-glycosylated sphingoid bases. These vinylogous amide compounds enable an easy and effective production of 1-O-glycosylated sphingoid bases.
    Type: Application
    Filed: June 14, 2019
    Publication date: October 28, 2021
    Inventors: Ferenc Horvath, Györgyi Osztrovszky, Gyula Dekany, Andras Nagy, Piroska Kovacs-Penzes, Jorge Santos
  • Publication number: 20210253536
    Abstract: The present invention relates to sphingolipids, a method for the production of sphingoid bases, especially sphingosine, and novel derivatives thereof. The sphingoid bases are herein produced by making use of a vinylogous amide-type protecting group. The resulting vinylogous amide compounds enable an easy and effective production of sphingoid bases, especially sphingosine.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 19, 2021
    Inventors: Gyula Dekany, Ferenc Horvath, Györgyi Osztrovszky, Jorge Santos, Piroska Kovacs-Penzes, Andras Nagy
  • Publication number: 20210161971
    Abstract: A cell genetically modified to comprise at least one mechanism for providing a local immunosuppression at a transplant site when transplanted in an allogeneic host, and methods for making and using the same are provided. The cell comprises a set of transgenes, each transgene encoding a gene product that is cytoplasmic, membrane bound, or local acting, and whose function is one or more of: to mitigate antigen presenting cell activation and function; to mitigate graft attacking leukocyte activity or cytolytic function; to mitigate macrophage cytolytic function and phagocytosis of allograft cells; to induce apoptosis in graft attacking leukocytes; to mitigate local inflammatory proteins; and to protect against leukocyte-mediated apoptosis. The transgenes comprise two or more of the following genes: PD-L 1, HLAG or H2-M3, Cd47, Cd200, FASLG or Fasl, Ccl21 or Ccl21b, Mfge8, and Serpin B9 or Spi6.
    Type: Application
    Filed: June 12, 2018
    Publication date: June 3, 2021
    Inventors: Andras NAGY, Jeffrey HARDING, Kristina NAGY
  • Patent number: 11003833
    Abstract: A layout engine generates a visual layout tree for a visual description tree of a document whose content is to be rendered in one or more display areas. A visual description tree describes the content of a document along with formatting and logical arrangement the content. Visual description nodes of a visual description tree represent the organization of the constituent elements a document hierarchically. A visual layout tree defines the layout of a document within one or more display areas. Visual layout nodes of a visual layout tree represent the layout of the content of a document hierarchically. The layout engine receives as input a visual description tree and generates the corresponding visual layout tree. A rendering engine then inputs the visual layout tree and generates a graphics buffer containing the pixels representing the layout of the document as defined by the visual layout tree.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: May 11, 2021
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Charles Simonyi, Andras Nagy
  • Patent number: 10721084
    Abstract: Groupware features are described that support asynchronous collaboration for a synchronous collaboration environment. During a synchronous collaboration session, a document is displayed at a user's computing device. As changes to the document are received at the user's computing device, a change list is updated and the modified document is displayed. Any changes from the user are broadcast to other participants. For asynchronous collaboration during the session, a user-specific fork is created in the change list to contain private changes for the user. For each private change from the user, the groupware updates the change list in the user-specific fork with the private change, which is not broadcast to the other participants for reconciliation.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: July 21, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Charles Simonyi, Eran Megiddo, Andras Nagy, Alexander Elijah Pardes
  • Publication number: 20200199492
    Abstract: The present invention is directed to biodegradable cleaning compositions, in particular hard surface cleaning compositions, and their use. The compositions according to the invention comprise one or more biosurfactants(s), one or more sorbitan ester(s) and one or more further surfactant(s), which is/are neither a biosurfactant nor a sorbitan ester.
    Type: Application
    Filed: April 26, 2018
    Publication date: June 25, 2020
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Zheng XUE, Andras NAGY, Dennis PARRISH, Sam CHRISTY, Jennifer GOODYEAR, Jeff DAVIDSON
  • Publication number: 20200016278
    Abstract: Provided herein are methods for facilitating or inducing stable transgene integration and expression in a proliferating cell, comprising administering to the cell (i) a recombinant AAV (rAAV) vector comprising the transgene flanked by transposon-derived inverted terminal repeat sequences, which sequences are in turn flanked by AAV-derived inverted terminal repeat regions, and (ii) a source of a transposase that recognises said transposon-derived inverted terminal repeat sequences and directs the genomic integration of the transgene into the genome of the proliferating cell. Also provide are methods and transgene delivery systems for the treatment or prevention of diseases affecting, associated with or characterised by proliferating cells.
    Type: Application
    Filed: June 24, 2019
    Publication date: January 16, 2020
    Inventors: Ian Alexander, Sharon Cunningham, Andras Nagy
  • Patent number: 10430500
    Abstract: A layout engine generates a visual layout tree for a visual description tree of a document whose content is to be rendered in one or more display areas. A visual description tree describes the content of a document along with formatting and logical arrangement the content. Visual description nodes of a visual description tree represent the organization of the constituent elements a document hierarchically. A visual layout tree defines the layout of a document within one or more display areas. Visual layout nodes of a visual layout tree represent the layout of the content of a document hierarchically. The layout engine receives as input a visual description tree and generates the corresponding visual layout tree. A rendering engine then inputs the visual layout tree and generates a graphics buffer containing the pixels representing the layout of the document as defined by the visual layout tree.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: October 1, 2019
    Assignee: INTENTIONAL SOFTWARE CORPORATION
    Inventors: Paul J. Kwiatkowski, Andras Nagy, Jeremy M. Price
  • Patent number: 10402478
    Abstract: A layout engine generates a visual layout tree for a visual description tree of a document whose content is to be rendered in one or more display areas. A visual description tree describes the content of a document along with formatting and logical arrangement the content. Visual description nodes of a visual description tree represent the organization of the constituent elements a document hierarchically. A visual layout tree defines the layout of a document within one or more display areas. Visual layout nodes of a visual layout tree represent the layout of the content of a document hierarchically. The layout engine receives as input a visual description tree and generates the corresponding visual layout tree. A rendering engine then inputs the visual layout tree and generates a graphics buffer containing the pixels representing the layout of the document as defined by the visual layout tree.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: September 3, 2019
    Assignee: Intentional Software Corporation
    Inventors: Charles Simonyi, Paul J. Kwiatkowski, Jeremy M. Price, Andras Nagy, Nicholas J. Wilson, Alexander K. Horton
  • Patent number: 10387547
    Abstract: A layout engine generates a visual layout tree for a visual description tree of a document whose content is to be rendered in one or more display areas. A visual description tree describes the content of a document along with formatting and logical arrangement the content. Visual description nodes of a visual description tree represent the organization of the constituent elements a document hierarchically. A visual layout tree defines the layout of a document within one or more display areas. Visual layout nodes of a visual layout tree represent the layout of the content of a document hierarchically. The layout engine receives as input a visual description tree and generates the corresponding visual layout tree. A rendering engine then inputs the visual layout tree and generates a graphics buffer containing the pixels representing the layout of the document as defined by the visual layout tree.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: August 20, 2019
    Assignee: INTENTIONAL SOFTWARE CORPORATION
    Inventors: Charles Simonyi, Paul J. Kwiatkowski, Jeremy M. Price, Andras Nagy, Nicholas J. Wilson, Alexander K. Horton
  • Patent number: 10325398
    Abstract: Techniques and systems for applying an ink effect to the drawing of an ink stroke can include absolute age for a digital ink stroke. A digital ink system can identify a reference time from which to represent a current time. The system can generate an absolute age of each ink point of the ink stroke based on the reference time. Then the ink effect can be applied to the ink stroke with a rhythm derived from when the ink stroke was originally drawn by using the absolute age of each ink point. In some cases, the rhythm can be the same rhythm as when the ink stroke was originally drawn. In other cases, the rhythm can be modified based on the rhythm the ink stroke was originally drawn. For example, the original rhythm may be accelerating, decelerating, skewed, compressed, affine, or non-affine.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: June 18, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Paul J. Kwiatkowski, Travis P. Dorschel, Andras Nagy, Taylor S. Williams, Simon J. Schaffer, Craig A. Macomber, Christine M. Johnson, Michael Tang, Joshua M. Smithrud
  • Publication number: 20190096114
    Abstract: Techniques and systems for applying an ink effect to the drawing of an ink stroke can include absolute age for a digital ink stroke. A digital ink system can identify a reference time from which to represent a current time. The system can generate an absolute age of each ink point of the ink stroke based on the reference time. Then the ink effect can be applied to the ink stroke with a rhythm derived from when the ink stroke was originally drawn by using the absolute age of each ink point. In some cases, the rhythm can be the same rhythm as when the ink stroke was originally drawn. In other cases, the rhythm can be modified based on the rhythm the ink stroke was originally drawn. For example, the original rhythm may be accelerating, decelerating, skewed, compressed, affine, or non-affine.
    Type: Application
    Filed: January 15, 2018
    Publication date: March 28, 2019
    Inventors: Paul J. Kwiatkowski, Travis P. Dorschel, Andras Nagy, Taylor S. Williams, Simon J. Schaffer, Craig A. Macomber, Christine M. Johnson, Michael Tang, Joshua M. Smithrud